Bathi saben saham sajrone rolas wulan pungkasan: Delcath Systems Inc (DCTH)
Due to its monopoly position in the treatment of metastatic melanoma, Delcath Systems, Inc. (DCTH) possesses significant pricing power. The 12-month net income per share history illustrates the dynamics of this process, where 0.15 captures a new level. The company leverages physician confidence in its unique liver perfusion system, scaling the business through the sale of high-margin consumables.
Rincian analitis lan laporan data perusahaan Delcath Systems Inc (DCTH)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Delcath Systems, Inc.|DCTH - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Delcath|DCTH - Utang perusahaan|Utang-utang marang kapitalisasi buku Delcath Systems, Inc.|DCTH - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Delcath Systems|Indikator likuiditas cepet delcath.com
- indikator pendapatan resik lan kelipatan nilai:
DCTH - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Delcath Systems, Inc.|DCTH - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Delcath Systems|DCTH - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Delcath Systems, Inc.|DCTH - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Delcath Systems|DCTH - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan delcath.com|DCTH - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Delcath Systems, Inc.
Pambiji fundamental perusahaan:Delcath Systems, Inc. (DCTH)
Delcath Systems, Inc. (DCTH) transition toward the commercialization of the HEPZATO KIT system shifts the company from the clinical development stage to a phase of real revenue generation. The TTM net income per share captures the total annual financial result distributed across all outstanding shares, allowing investors to assess the business's actual viability and expansion rates while filtering out market noise through the analysis of this chart.
Analisis pesaing
ONC: Bathi resik saben saham sajrone 12 wulan pungkasan|HALO - Bathi resik saben saham (EPS TTM)|Revolution Medicines, Inc. (RVMD) - Bathi saben saham sajrone rolas wulan pungkasan|Ascentage Pharma Group International - Bathi saben saham sajroning taun lumaku|CGON (CG Oncology Corp) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan UroGen Pharma Corp URGN|Bathi resik saben saham (EPS TTM) BCAX|personalis.com - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) ERAS (Erasca)|Y-mAbs Therapeutics Inc (YMAB) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|AURA - Bathi saben saham sajrone rolas wulan pungkasan|CADL: Bathi saben saham sajrone rolas wulan pungkasan|ARAY: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan SELLAS Life Sciences Group|ACTU (Actuate Therapeutics) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Citius Oncology Inc.|Bathi resik saben saham sajrone 12 wulan pungkasan HURA (TuHURA Biosciences, Inc.)|Bathi saben saham sajrone patang kuartal pungkasan TARA|Bathi resik saben saham (EPS TTM) FATE (Fate Therapeutics, Inc.)|Bathi saben saham sajroning taun lumaku WHWK|TCRX: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku CSBR (Champions Oncology)|xbiotech.com (XBIT) - Bathi saben saham sajrone rolas wulan pungkasan|CVM - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan OSTX|Bathi resik saben siji saham sajrone rolas wulan pungkasan radiopharmtheranostics.com RADX|Bathi saben saham sajrone rolas wulan pungkasan Artiva Biotherapeutics, Inc. (ARTV)|Bathi resik saben saham sajrone patang kuartal pungkasan adlainortye.com|Veru Pharma - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan TPST (Tempest Therapeutics Corp)|Xilio - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Renovaro Inc.|muraloncology.com (MURA) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan Kairos Pharma|Bathi saben saham sajrone rolas wulan pungkasan OnKure Therapeutics, Inc.|CytoMed (GDTC) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan CRIS (Curis, Inc.)|APLM (apollomicsinc.com) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) THAR (Tharimmune)|Bathi resik saben saham sajrone patang kuartal pungkasan Advanced Biomed Inc. (ADVB)|GNPX - Bathi saben saham sajrone rolas wulan pungkasan|CLDI (Calidi Biotherapeutics) - Bathi saben saham sajrone 12 wulan pungkasan|SBFM: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan Xenetic Biosciences, Inc.|Bathi resik saben saham sajrone 12 wulan pungkasan SLRX|Purple Biotech Ltd (PPBT) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham (EPS TTM) AONC|BeiGene Ltd - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) CKPT (Checkpoint Therapeutics)|ELEV - Bathi resik saben saham sajrone 12 wulan pungkasan|ICAD: Bathi resik saben saham sajrone 12 wulan pungkasan|Ikena Oncology, Inc. - Bathi saben saham sajrone patang kuartal pungkasan|NTBL: Bathi resik saben saham (EPS TTM)|Viracta Therapeutics, Inc. - Bathi saben saham sajroning taun lumaku|MOR (MorphoSys AG) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan nayabiosciences.com (NAYA)|Bathi resik saben saham (EPS TTM) AAPGV
